130 related articles for article (PubMed ID: 5434836)
1. Vasodilators in prevention and treatment of ischemic stroke.
Taylor JR
J Iowa Med Soc; 1970 Apr; 60(4):258-61. PubMed ID: 5434836
[No Abstract] [Full Text] [Related]
2. Cerebral vasodilators.
Br Med J; 1971 Jun; 2(5763):702-3. PubMed ID: 4933650
[No Abstract] [Full Text] [Related]
3. Treatment of cerebral ischemia with vasoactive drugs.
Klassen AC
Postgrad Med; 1972 Feb; 51(2):199-203. PubMed ID: 5019715
[No Abstract] [Full Text] [Related]
4. Cerebral vasodilator therapy in stroke.
McHenry LC
Stroke; 1972; 3(6):686-91. PubMed ID: 4629450
[No Abstract] [Full Text] [Related]
5. Cydandelate for cerebrovascular disease.
Drug Ther Bull; 1968 Nov; 6(23):92. PubMed ID: 5697287
[No Abstract] [Full Text] [Related]
6. Cerebral vasodilators.
Judge TG
Br Med J; 1971 Aug; 3(5772):480. PubMed ID: 4936031
[No Abstract] [Full Text] [Related]
7. A preliminary study of the effects of cyclandelate.
Davies G
Med J Aust; 1971 Feb; 1(6):313-7. PubMed ID: 4925923
[No Abstract] [Full Text] [Related]
8. [Use of hydergine in acute ischemic pathology of the brain].
Gomensoro JB
Acta Neurol Latinoam; 1967; 13(1):273-82. PubMed ID: 4976823
[No Abstract] [Full Text] [Related]
9. Cerebral vasodilators.
Hall P
Br Med J; 1971 Aug; 3(5770):374. PubMed ID: 5558206
[No Abstract] [Full Text] [Related]
10. Cyclandelate and mental functions: a double-blind cross-over trial in normal elderly subjects.
Judge TG; Urquhart A; Blakemore CB
Age Ageing; 1973 May; 2(2):121-4. PubMed ID: 4591604
[No Abstract] [Full Text] [Related]
11. [The effects of vasodilators on the cerebral hemodynanics in the cerebrovascular diseases].
Furuhashi N
Nihon Naika Gakkai Zasshi; 1971 Feb; 60(2):89-102. PubMed ID: 4396692
[No Abstract] [Full Text] [Related]
12. [Treatment and prevention of cerebral arterial disorders in aged and of their consequences. Rheoencephalographic examinations].
Albot G; Goutmer B; Treps J
Therapeutique; 1971; 47(6):579-84. PubMed ID: 5571174
[No Abstract] [Full Text] [Related]
13. Chronic cerebrovascular disorders: a clinical study with cyclandelate.
Bassi S; Albizzati MG; Sbacchi M; Frattola L
Br J Clin Pract; 1984 Oct; 38(10):344-9. PubMed ID: 6498057
[No Abstract] [Full Text] [Related]
14. Clinical effects of Cyclospasmol in patients affected by chronic cerebrovascular disorders.
Albizzati MG; Bassi S; Sbacchi M; Frattola L
Br J Clin Pract Suppl; 1984; 34():69-73. PubMed ID: 6430327
[No Abstract] [Full Text] [Related]
15. [Medical treatment of acute disorders of cerebral circulation].
Buscaino GA
Acta Neurol Quad (Napoli); 1980; 41():74-81. PubMed ID: 7293741
[No Abstract] [Full Text] [Related]
16. [Effect of the mandelic ester of 3,5,5-trimethyl-cyclohexanol (Cyclospasmol) on blood flow potentials in peripheral obstructive arteriopathies].
Russo A; Azzolina P; Biondi M; Montemagno S; Giovinetto A
Minerva Med; 1969 Aug; 60(69):3110-6. PubMed ID: 5824709
[No Abstract] [Full Text] [Related]
17. Improvement in brain oxygenation and clinical improvement in patients with strokes treated with papaverine hydrochloride.
Meyer JS; Gotoh F; Gilroy J; Nara N
JAMA; 1965 Nov; 194(9):957-61. PubMed ID: 5897963
[No Abstract] [Full Text] [Related]
18. The use of cyclandelate in chronic brain syndrome with arteriosclerosis.
Fine EW
Curr Ther Res Clin Exp; 1971 Sep; 13(9):568-74. PubMed ID: 5000458
[No Abstract] [Full Text] [Related]
19. The clinical efficacy of Cyclospasmol: a review of the literature.
Blakemore CB
Br J Clin Pract Suppl; 1984; 34():3-9. PubMed ID: 6430319
[No Abstract] [Full Text] [Related]
20. Electroencephalographic study of dose-response relations for cyclandelate on hyperventilation-induced vasospasm in human brain.
Korenyi C; Whittier JR
Angiology; 1969 Oct; 20(9):529-34. PubMed ID: 5824354
[No Abstract] [Full Text] [Related]
[Next] [New Search]
